Quantification of the individual enantiomer plasma concentrations of the candidate antimalarial agent N^4-[2,6-dimethoxy-4-methyl-5-[(3-trifluoromethyl)phenoxy]-8-quinolinyl]-1,4-pentanediamine (WR 238,605)

Division Of Oncology And Pulmonary Drug Products Food And Drug Administration

Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Res

Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Res

Department of Pharmacology, Division of Experimental Therapeutics, Walter Reed Army Institute of Res

Department Of Pharmacology Division Of Experimental Therapeutics Walter Reed Army Institute Of Resea

Department Of Pharmacology Division Of Experimental Therapeutics Walter Reed Army Institute Of Resea

Department Of Pharmacology Division Of Experimental Therapeutics Walter Reed Army Institute Of Resea